AltairTrading Analysis Report: CDE¶
Analysis date: 2026-09-28 · Model: gpt-6-astra · AI-generated, not financial advice.
Generated: 2026-09-28 19:52:00
V. Portfolio Manager Decision¶
Rating: Underweight
Executive Summary: Reduce CDE exposure to no more than the lesser of 0.5x the caller's standard position allocation and the amount permitted by the portfolio's risk budget, accounting for other metals holdings and plausible gap losses; this is a ceiling, not a target or half the portfolio. If above that limit, check current tradable prices and sell the excess in two roughly equal liquid tranches where practical, without waiting for a rebound or delaying correction of a serious risk-limit breach. If within the limit, do not add or short; if uninvested, defer initiation, and reduce existing exposure further if aggregate portfolio risk warrants it. Reassess at the next company-issued operating/financial update, whose date is not supplied; historical September 28 prices are not live orders or stops, and the supplied evidence does not support a price target or fixed-price stop.
Price Target: not provided
Time Horizon: Until CDE's next company-issued operating/financial update; date not provided.
IV. Risk Management Team Decision¶
Aggressive Analyst¶
Aggressive Analyst: I’d back the SELL, but not as a retreat from risk. If CDE is above half a normal allocation, trimming the excess is a way to take risk more deliberately: free up capacity while the near-term case is deteriorating, and retain a meaningful stake if the longer-term turnaround wins out.
The case for acting is stronger than a single bad close. As of September 28, CDE had fallen from $22.21 on August 27 to $17.87, closing at the day’s low and below its $18.71 50-day average. Weekly and daily SuperTrend were down, the MACD histogram had worsened to −0.33, and OBV had roughly halved from its August reading. Fundamentally, Q2 free cash flow of $387.5 million is impressive, but gross margin dropped from 49.8% to 25.8% quarter over quarter, diluted EPS fell from $0.35 to $0.12, and the roughly 60% increase in reported shares makes the payoff per share less clear. Keeping a full allocation through that combination isn’t the bold choice; it’s an unexamined bet that the turnaround will outrun dilution and costs.
I also wouldn’t take those warnings as a reason to liquidate. CDE had about $339 million in reported net cash at June 30, record-revenue potential from the acquired mines, and a monthly SuperTrend that remained up. Its daily Z-score of −2.34 leaves room for a sharp rebound, while ADX of 16.01 does not confirm a strong, orderly downtrend. The better high-upside trade-off is to keep half-sized participation without letting a possible rebound dictate the whole position.
If holdings exceed 0.5x the normal allocation, sell the excess in two roughly equal tranches after checking tradable prices and liquidity. If holdings are already at or below that cap, don’t add or initiate a short. The September 28 prices are evidence for the decision, not live order levels or fixed stops. Aggressive Analyst: I still back the conditional SELL for CDE. Conservative analyst, you’re right that half a standard allocation is a ceiling, not a target. I’m not arguing that dated June net cash or an upward monthly SuperTrend makes any holding mandatory. I’m arguing that, if CDE is oversized, keeping the excess is an aggressive bet with worsening near-term evidence and no demonstrated per-share payoff.
CDE fell about 20% from its August 27 close to its September 28 close of $17.87. It finished that day at the low, below the $18.71 50-day average, with weekly and daily SuperTrend down, a worsening MACD histogram, and falling OBV. Record Q2 revenue and $387.5 million of free cash flow make the turnaround worth watching, but revenue growth did not prevent gross margin falling from 49.8% to 25.8% or diluted EPS dropping from $0.35 to $0.12. After a roughly 60% rise in reported shares, the upside must ultimately show up per share. Trimming now frees risk capacity rather than requiring a full-sized commitment while that test remains unresolved.
Your rebound warning strengthens the case for a trim instead of liquidation or a short. A daily Z-score of −2.34 and ADX of 16.01 make a sharp reversal plausible; they do not make an oversized position attractive. Neutral analyst, I also agree that existing metals exposure and the actual risk budget may warrant less than half a normal allocation. But requiring every operating, metals, and technical question to be settled before retaining an affordable small stake risks missing the upside from a rebound. Those checks are more compelling prerequisites for adding than for keeping limited participation.
So my recommendation remains SELL only CDE holdings above the applicable cap: at most 0.5 times the normal allocation, and less if the caller’s risk budget requires it. Sell the excess in two roughly equal liquid tranches after checking a current tradable quote. If already within that limit, do not add or short. The September 28 prices and $1.02 ATR inform the risk decision; none is a live order level or a guaranteed stop. Aggressive Analyst: Conservative, you’re right that 0.5x is a ceiling, not a stake CDE must retain. Other metals holdings, the actual risk budget, and gap risk could justify less. But the $1.02 ATR—about 5.7% of the September 28 close—also makes the case for acting on an oversized position now, rather than waiting for mine-level certainty. The daily Z-score of −2.34 and ADX of 16.01 do not promise a rebound; they argue against turning this SELL into a liquidation or short when a small, affordable holding could still participate in one.
You’re also right that Q2’s $387.5 million of reported free cash flow and June’s roughly $339 million net cash do not settle the margin, dilution, or cash-flow-reconciliation questions. That is precisely why I would sell the excess. CDE’s gross margin fell from 49.8% to 25.8% and diluted EPS from $0.35 to $0.12, while reported shares rose roughly 60%. A full allocation demands more confidence in future returns per share than the evidence supports. Yet record revenue and the still-positive monthly trend leave upside worth preserving if the residual position fits the portfolio. Recent metals weakness and rising nominal yields strengthen the trim case; I would not claim an unverified real-yield move or a lasting metals downturn.
Neutral, I agree that a roughly 20% decline, falling OBV, and bearish weekly trend do not guarantee another leg down. They do make carrying excess CDE risk a poor way to pursue upside. Nor would I wait for every filing and operating question to be resolved before retaining an affordable small stake: those are stronger tests for adding. The mixed, low-confidence sentiment—eight bullish-tagged StockTwits posts out of 18, with caution in unlabeled posts—is no confirmation, but it reinforces why an all-or-nothing exit could miss a sharp reversal.
My call remains SELL CDE only above the smaller of 0.5x a standard allocation and the portfolio’s affordable risk limit, accounting for other metals exposure. Check a current tradable quote, then sell the excess in two roughly equal liquid tranches where practical; do not prolong a serious risk-budget breach to follow that schedule. If already within the appropriate limit, do not add or short, and reassess whether even that holding is affordable. September 28 prices are evidence, not live orders or fixed stops. Aggressive Analyst: Conservative, I agree that half a normal allocation is a ceiling, not a destination. A $1.02 ATR—about 5.7% of CDE’s September 28 close—and the possibility of a larger gap argue for trimming an oversized position promptly. They do not, by themselves, make zero exposure the best choice for a portfolio that can afford a small holding. CDE’s reported first-half 2026 free cash flow of $654.3 million nearly matched all of 2025, even as Q2 margins and EPS deteriorated. That tension is the opportunity: the turnaround is not proven per share, but neither is it disproven. The daily oversold reading and weak ADX add rebound potential, not protection against loss.
Neutral, you are right not to treat bullish social tags or the positive monthly trend as a near-term buy signal. I would not. But dismissing CDE’s cash generation while waiting for every acquired-mine and share-count question to be resolved could surrender upside before the evidence improves. The roughly 20% decline from August 27 to September 28 shows why a full position is hard to defend; it also shows why an affordable residual stake has value if the operating case recovers. The vendor totals and per-share economics need checking before adding, not necessarily before retaining limited exposure. Nor do rising nominal yields establish an unverified real-yield move or a lasting metals downturn.
My call is therefore SELL the excess CDE holding above the smaller of 0.5 times a standard allocation and the portfolio’s actual risk allowance, including other metals exposure. Check a current tradable quote and use two roughly equal liquid tranches where practical; correct a serious limit breach without waiting for that schedule. If already within the appropriate limit, do not add or short, and reduce further if the residual is still unaffordable. September 28 prices are evidence for that decision, not live orders or fixed stops. Aggressive Analyst: Conservative, you’re right that CDE’s reported cash flow does not prove durable returns per share. Q2 gross margin fell from 49.8% to 25.8%, diluted EPS fell from $0.35 to $0.12, and the roughly 60% increase in reported shares demands an explanation. But that is an argument for selling excess exposure, not for treating the upside as imaginary. Reported first-half free cash flow of $654.3 million nearly matched all of 2025. If the acquired mines deliver that cash generation on a sustainable, per-share basis, waiting for every uncertainty to disappear could mean missing a substantial repricing. The vendor totals need reconciliation before adding; they do not erase the reported quarterly cash generation.
You’re also right that a daily Z-score of −2.34 and ADX of 16.01 offer no downside protection. Their strategic value is narrower: they make a smooth continued decline uncertain. That favors a trim over an automatic liquidation or short. And I agree that June’s net cash and the positive monthly trend are not today’s safety net. The portfolio risk budget—including other metals holdings—must decide whether any residual CDE position is affordable.
Neutral, I agree a rebound cannot justify holding CDE in an already concentrated portfolio. Where I differ is in calling the cash-flow-versus-margin tension merely something to watch. An affordable small stake is a deliberate way to keep access to the potential turnaround while selling the portion that requires too much confidence in it. Meanwhile, CDE’s September 28 close of $17.87 was below its $18.71 50-day average, with weekly and daily SuperTrend down, worsening MACD and falling OBV. Those signals make carrying an oversized bet the wrong form of aggression. Recent metals weakness adds urgency, though it proves neither a lasting metals downturn nor a rise in real yields.
My call is SELL CDE holdings above the lesser of 0.5 times a normal allocation and the portfolio’s actual risk allowance. Check a current tradable quote; sell the excess in two roughly equal liquid tranches where practical, without delaying correction of a serious risk-limit breach. If already within the appropriate limit, do not add or short, and reduce further if combined exposure makes even that holding unaffordable. September 28 prices are historical evidence, not live order levels or stops.